As the global leader in finance, policy, art, research, and medicine, the region is well-positioned to lead neurotech. We help foster and promote the local neurotech ecosystem: clinics, companies, funders, labs, and users.
Inventing the future: A neuroscience research roadmap
The past decade of transformative advances in neurotechnology portends an exciting future for neuroscience. This NeuroView charts a strategic path to accelerate and integrate research discovery and speed the development of new cures for human brain disorders.
NYC Neurotech Company List
Massively Scalable Neurotechnologies
Backed by £50m, this programme sits within the Scalable Neural Interfaces opportunity space and is seeking radically new ways to deliver responsive neurotechnologies to the brain without brain surgery.
Just back from a truly impactful few days at Asilomar for the Brain and Mind, hosted by the brilliant team at BrainMind. The spirit of the 1975 Recombinant DNA Conference felt palpable as we gathered… | Sean White
Just back from a truly impactful few days at Asilomar for the Brain and Mind, hosted by the brilliant team at BrainMind. The spirit of the 1975 Recombinant DNA Conference felt palpable as we gathered to chart ethical standards for the accelerating field of Neurotech. While our focus was on neuroethics, from investor diligence questions and board-level risk matrices to user/stakeholder engagement and toolkits for neuroentrepreneurs, the key themes shared a powerful parallel with AI Ethics: maintain and enhance human agency, combat misuse and mistrust, and acknowledge that innovation is moving faster than its guardrails. Both fields present novel challenges that demand we adapt our existing frameworks and principles to meet new challenges. At the heart of it all is human agency. Whether we're discussing neurodevices or large language models, our core responsibility as builders, executives, investors, and policymakers is to ensure people are informed, in control, and never burdened to fight for their own empowerment or autonomy. We have the fundamental responsibility to care about the people we serve. This commitment to responsible, human-centric development is fundamental to our work at Inflection AI. We're building with emotional intelligence at the core. Every product decision we make starts with a simple question: does this expand what people can do, or does it quietly shift the burden onto them? AI should work for the humans using it, amplifying judgment, not replacing it. Earning trust through transparency rather than demanding it through dependency. A special thank you to Diana Saville for once again outdoing herself at every event and to Michael McCullough, MD for his endless support of the ecosystem. And to all the Braingels who showed up and rolled up their sleeves! Let's translate the urgency from Asilomar into action and continue to drive positive change.
Why A Neurotech VC Bet On Anthropic: Intelligence, Interpretability, and the NeuroAI Stack — Kaleida Capital
Why would a neurotech VC bet on Anthropic? This article examines how frontier AI, neuroscience, model behavior, and intelligent systems intersect within Kaleida Capital’s NeuroAI thesis and the infrastructure shaping next-generation intelligence.
Partner with Neuroscience
Partner with J&J Neuroscience to collaborate on licensing, academia, venture deals and shared innovation across Alzheimer’s, Parkinson’s and more.
Neuroscience needs a career path for software engineers
Few institutions have mechanisms for the type of long-term positions that would best benefit the science.
Blueprint Neurotech
The Center for Innovative NeuroTech Advancement (CINTA) & NeuroTech Harbor (NTH) announce the Cycle 6 Award Competition supported by the NIH Blueprint MedTech Program. This program is seeking collaborative projects aimed at developing emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system that are aligned with the mission and interests of the participating NIH institutes and centers.
Ground Effect Ventures
Operator-led venture capital investing in Signal-Rich NeuroTech and High Impact Medtech.
Yneuro | The startup behind Neuro ID®
Imagine a world where technology and human experience blend seamlessly. At Yneuro, we’re building that world. As pioneers in neurotechnology, we craft AI-driven software solutions that transcend global barriers. Celebrated in startup ecosystems and competitions, Yneuro is redefining digital interaction, making advanced technologies intuitive and accessible for everyone. Join us as we merge technology and human cognition, creating unprecedented possibilities.
Funding and Framing Impact in the Neuro Frontier
Representations 04: Philanthropy, FRO, Connectomes, ARIA
BrainMind
At this important juncture in neuroscience, the BrainMind ecosystem is combining the most talented of these groups in novel ways to collectively shepherd, support, and fund ideas that can be translated from labs into interventions that will benefit humanity.
Leading Innovation in Psychiatric Treatment | Alto Neuroscience
We leverage brain biology to develop personalized medicines, helping patients get better faster.
Motif Neurotech — Therapeutic Brain Computer Interface For Mental Health
We're building devices to help you monitor and regulate your mental health and performance.
.png)
Jeff Bezos Is Funding a Wild Hunt for the Brain’s ‘Core Algorithm’
With $500 million in funding and a reported $2.5 billion valuation, Flourish wants to reinvent AI by putting real neurons under the microscope.
About Patrick Mineault
I’m an AI researcher and neurotechnologist. I’m a NeuroAI researcher at the Amaranth Foundation. I’m always happy to take on new, manifestly important projects that are nearly imp…
